{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:09:36Z","timestamp":1793660976613,"version":"4.5.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.vaccine.2024.07.020","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T21:26:41Z","timestamp":1720819601000},"page":"126119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-8672","authenticated-orcid":false,"given":"Florencia A.","family":"Bonnin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2635-474X","authenticated-orcid":false,"given":"Laura B.","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3644-372X","authenticated-orcid":false,"given":"Fausto M.","family":"Ferolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio L.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-9698","authenticated-orcid":false,"given":"Emily","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azad","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00eda","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0076-5903","authenticated-orcid":false,"given":"Ana","family":"Caratozzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Neira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normando","family":"Mascardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Satragno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4747-6626","authenticated-orcid":false,"given":"Mar\u00eda M.","family":"Contrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8112-0853","authenticated-orcid":false,"given":"Barney S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-7169","authenticated-orcid":false,"given":"Tracy J.","family":"Ruckwardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.07.020_b0005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.07.020_b0010","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"725\u201332","key":"10.1016\/j.vaccine.2024.07.020_b0015","first-page":"32A","article-title":"Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis","volume":"89","author":"Moisi","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.07.020_b0020","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.07.020_b0025","doi-asserted-by":"crossref","unstructured":"Carroll KN, Hartert TV. The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations. Immunol Allergy Clin North Am 2008;28:539\u201361, viii. doi: 10.1016\/j.iac.2008.03.001.","DOI":"10.1016\/j.iac.2008.03.001"},{"key":"10.1016\/j.vaccine.2024.07.020_b0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.201301-0016OC","article-title":"Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children","volume":"187","author":"Ferolla","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2024.07.020_b0035","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(22)00291-2","article-title":"Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape","volume":"23","author":"Mazur","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.07.020_b0040","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.07.020_b0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.07.020_b0050","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.07.020_b0055","series-title":"Fields virology","author":"Knipe","year":"2013"},{"key":"10.1016\/j.vaccine.2024.07.020_b0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.immuni.2019.08.007","article-title":"Immunological lessons from respiratory syncytial virus vaccine development","volume":"51","author":"Ruckwardt","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2024.07.020_b0065","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.07.020_b0070","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.07.020_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.271","article-title":"A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein","volume":"2","author":"Mousa","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.coviro.2017.03.012","article-title":"Vaccine development for respiratory syncytial virus","volume":"23","author":"Graham","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0085","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2214773","article-title":"Nirsevimab for prevention of RSV in term and late-preterm infants","volume":"388","author":"Muller","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.07.020_b0090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1908380","article-title":"Respiratory syncytial virus vaccination during pregnancy and effects in infants","volume":"383","author":"Madhi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.07.020_b0095","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/JCM.02270-10","article-title":"Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens","volume":"49","author":"Kodani","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0100","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1128\/JCM.00097-10","article-title":"Molecular quantification of respiratory syncytial virus in respiratory samples: reliable detection during the initial phase of infection","volume":"48","author":"van de Pol","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/JCM.01739-07","article-title":"Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses","volume":"46","author":"Lu","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/JCM.42.3.981-986.2004","article-title":"Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages","volume":"42","author":"Maertzdorf","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-8-332","article-title":"Real-world comparison of two molecular methods for detection of respiratory viruses","volume":"8","author":"Ali","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2024.07.020_b0120","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1056\/NEJMoa060930","article-title":"Three Indonesian clusters of H5N1 virus infection in 2005","volume":"355","author":"Kandun","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.07.020_b0125","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/JCM.02202-06","article-title":"Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenza","volume":"45","author":"Mehlmann","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7010023","article-title":"Epitope-specific serological assays for RSV: conformation matters","author":"Phung","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.07.020_b0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2024.07.020_b0140","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/infdis\/jix489","article-title":"Prefusion F, Postfusion F, G antibodies, and disease severity in infants and young children with acute respiratory syncytial virus infection","volume":"216","author":"Capella","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.07.020_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166706","article-title":"Absence of association between cord specific antibody levels and severe respiratory syncytial virus (RSV) disease in early infants: a case control study from coastal Kenya","volume":"11","author":"Nyiro","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.07.020_b0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcv.2017.08.017","article-title":"Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal","volume":"95","author":"Chu","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170877","article-title":"Characteristics of RSV-specific maternal antibodies in plasma of hospitalized, acute RSV patients under three months of age","volume":"12","author":"Jans","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.07.020_b0160","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/infdis\/jiab315","article-title":"Respiratory syncytial virus (RSV)-specific antibodies in pregnant women and subsequent risk of RSV hospitalization in young infants","volume":"225","author":"Koivisto","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.07.020_b0165","doi-asserted-by":"crossref","first-page":"e4421","DOI":"10.1093\/cid\/ciaa648","article-title":"Respiratory syncytial virus (RSV) neutralizing antibodies at birth predict protection from RSV illness in infants in the first 3 months of life","volume":"73","author":"Buchwald","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.07.020_b0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/INF.0b013e31815ac585","article-title":"The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease","volume":"27","author":"Eick","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.07.020_b0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijid.2021.06.015","article-title":"Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection","volume":"109","author":"Taleb","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.07.020_b0180","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1513\/AnnalsATS.201806-380AW","article-title":"Host and viral determinants of respiratory syncytial virus-induced airway mucus","volume":"15","author":"Stier","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.vaccine.2024.07.020_b0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.iac.2019.04.001","article-title":"Importance of virus characteristics in respiratory syncytial virus-induced disease","volume":"39","author":"San-Juan-Vergara","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.vaccine.2024.07.020_b0190","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1128\/CMR.00090-16","article-title":"The human immune response to respiratory syncytial virus infection","volume":"30","author":"Russell","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.07.020_b0195","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/infdis\/jiy655","article-title":"Viral load dynamics and clinical disease severity in infants with respiratory syncytial virus infection","volume":"219","author":"Garcia-Maurino","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.07.020_b0200","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/infdis\/jiaa076","article-title":"Association of viral load with disease severity in outpatient children with respiratory syncytial virus infection","volume":"222","author":"Uusitupa","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.07.020_b0205","doi-asserted-by":"crossref","first-page":"e4384","DOI":"10.1093\/cid\/ciaa1612","article-title":"Respiratory syncytial virus disease severity in young children","volume":"73","author":"Haddadin","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.07.020_b0210","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/jmv.23455","article-title":"Association of the CT values of real-time PCR of viral upper respiratory tract infection with clinical severity","volume":"85","author":"Fuller","year":"2013","journal-title":"Kenya J Med Virol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0215","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jmv.24687","article-title":"Clinical characteristics and viral load of respiratory syncytial virus and human metapneumovirus in children hospitaled for acute lower respiratory tract infection","volume":"89","author":"Yan","year":"2017","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2024.07.020_b0220","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/infdis\/jiy106","article-title":"Virus-specific antibody, viral load, and disease severity in respiratory syncytial virus infection","volume":"218","author":"Walsh","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.07.020_b0225","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/jmv.21026","article-title":"Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity","volume":"79","author":"Fodha","year":"2007","journal-title":"J Med Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T18:57:49Z","timestamp":1726167469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24007813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":45,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0264410X24007813"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.07.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126119"}}